Free Motion for Miscellaneous Relief - District Court of Delaware - Delaware

Case 1:05-cv-00336-SLR

Document 164-2

Filed 10/22/2007

Page 1 of 5

EXHIBIT A

Case 1:05-cv-00336-SLR

Document 164-2

Filed 10/22/2007

Page 2 of 5

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ITEM DEVELOPMENT AB, ASTELLAS US LLC and ASTELLAS PHARMA US, INC., Plaintiffs, v. SICOR INC. and SICOR PHARMACEUTICALS, INC., Defendants. ) ) ) ) ) ) ) ) ) ) )
)

Civil Action No. 05-336 SLR

JUDGMENT AND INJUNCTION ON CONSENT Plaintiffs Astellas US LLC and Astellas Phaillia US, Inc. (hereinafter collectively "Astellas"), and Item Development AB (hereinafter "Item") and Defendants Sicor Inc. and Teva Parenteral Medicines, Inc. (foinierly known as Sicor Pharmaceuticals, Inc.)" (hereinafter collectively "Sicor"), have agreed to terms and conditions representing a negotiated settlement of this action and have set forth those terms and conditions in a Settlement Agreement. Now the parties, by their respective undersigned attorneys, hereby stipulate and consent to entry of judgment in this action as follows: It is HEREBY ORDERED, ADJUDGED, AND DECREED:
1. This Court has jurisdiction over the subject matter of this action and has personal jurisdiction over the parties. 2. With respect to Count H of the Complaint herein, seeking a declaratory judgment of infringement under 35 U.S.C. § 271(b) and (c), Sicor admits for

Case 1:05-cv-00336-SLR

Document 164-2

Filed 10/22/2007

Page 3 of 5

itself and its Affiliates (as defined in the Settlement Agreement) that claims 1, 3, 7, and 9 of U.S. Patent No. 5,731,296 (the "Asserted Claims") would be infringed by use, importation, offer for sale, or sale of the adenosine product, Adenosine Injection, USP labeled for use in myocardial perfusion imaging described in Sicor's Abbreviated New Drug Application No. 77-425 (the "Sicor ANDA Product"), except as provided in the Settlement Agreement. 3. Sicor further admits for itself and its Affiliates (as defined in the Settlement Agreement) that the Asserted Claims are valid and enforceable as to the Sicor ANDA Product and any product only colorably different therefrom. 4. Sicor and its Affiliates (as defined in the Settlement Agreement) shall not market the Sicor ANDA Product except as provided in the Settlement Agreement. 5. Counts I and 111 of the Complaint herein, seeking a judgment of infringement under 35 U.S.C. § 271(e)(2), are dismissed without prejudice. 6. This Court retains jurisdiction to enforce or supervise performance under this Judgment and Injunction on Consent and the Settlement Agreement. 7. Each party shall bear its own costs and attorneys' fees.

Dated: October 22, 2007

/s/ Richard K. Herrmann Approved as to form: Richard K. Herrmann #405 Mary B. Matterer # 2696 MORRIS JAMES LLP 500 Delaware Avenue, Suite 1500 Wilmington, DE 19801-1494 (302) 888-6800 [email protected] [email protected]

/s/ Karen L. Pascale Approved as to form: Josy W. Ingersoll #1088 Karen L. Pascale #2903 YOUNG CONAWAY STARGATT & TAYLOR, LLP The Brandywine Building 1000 West Street Wilmington, DE 19801 (302) 571-6672 [email protected] [email protected]

2

Case 1:05-cv-00336-SLR

Document 164-2

Filed 10/22/2007

Page 4 of 5

Charles E. Lipsey FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LLP Two Freedom Square 11955 Freedom Drive Reston, VA 20190-5675 (571) 203-2700 Susan H. Griffen David P. Frazier FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LLP 901 New York Avenue Washington, D.C. 20001-4413 (202) 408-4000 Attorneys for Plaintiffs Astellas US LLC and Astellas Pharma US, Inc.

David M. Hashmall, P.C. Annemarie Hassett GOODWIN PROCTOR LLP 599 Lexington Avenue New York, NY 10022 [email protected] [email protected] Attorneys for Defendants Sicor Inc. and Sicor Pharmaceuticals, Inc.

/s/ David E. Brand Approved as to form: Paul M Lukoff #96 David E. Brand #201 PRICKETT JONES & ELLIOTT, P.A. 1310 King Street Wilmington, DE 19801 (302) 888-6520 [email protected] [email protected]

John Scheibeler WHITE & CASE LLP 1155 Avenue of the Americas New York, NY 10036 (212) 819-8200 Attorneys for Plaintiff Item Development AB

3

Case 1:05-cv-00336-SLR

Document 164-2

Filed 10/22/2007

Page 5 of 5

SO ORDERED this ____ day of ______________ , 2007.

______________________________ United States District Judge

4